Xiaoyu An - Crown Biosci Inc | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 44 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Oxazolone induced atopic dermatitis mouse model using hIL-4/hIL-4Ra double knock-in mice, a preclinical mouse model for evaluating Dupilumab biosimilars

Tao Yang, Rongfei Lu, Xiaofei Xu,Likun Zhang, Dawei Wang, Xinhe Feng,Xiaoyu An,Jessie (Jingjing) Wang,Xianfei He, Carl K. Edwards

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 5118: STING agonist and TLR7/8 agonist overcome anti-PD-1 resistance mediated by loss of β2M

Hua Li, Chenpan Nie, Lin J,Annie Xiaoyu An, Ludovic Bourré, Jingjing Wang

Cancer Researchno. 7_Supplement (2023): 5118-5118

引用0浏览0引用

Abstract 4168: BALB/c-CD3EDG HuGEMMTM mouse model for evaluation of CD3-targeted tumor immunotherapy

D. Liu,Kaixia Lian, Yan Xin, Jie Lin, Zheng Li,Annie Xiaoyu An, Xiaolong Xu, Ludovic Bourré, Jingjing Wang

Cancer Researchno. 7_Supplement (2023): 4168-4168

引用0浏览0引用

Abstract 2980: HX009, a first-in-class PD1xCD47 BsAb, demonstrated anti-AML activity in PDX models

Xiaoyu An, Jinping Liu,Hang Ke,Lingxin Xiong,Xiaolong Tu, Lei Zhang,Faming Zhang,Henry Li

Cancer Researchno. 7_Supplement (2023): 2980-2980

引用1浏览0引用

HX009, a first-inclass PD1xCD47 BsAb, demonstrated anti-AML activity in PDX models

Xiaoyu An,Jinping Liu,Hang Ke,Lingxin Xiong,Xiaolong Tu, Lei Zhang,Faming Zhang,Henry Li

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 5665: HX301 (ON1232580) a novel kinase inhibitor with potent activity against CSF1R and FLT3, shows strong anti-AML activity in defined preclinical models

Xiaoyu An,Henry Li,Lei Xue, Jinping Liu,Lingxin Xiong,Hang Ke,Cen Chen, Bing Gao, Jun Zheng,Zheng-Zheng Bao,Sheng Guo, Lei Zhang,

Cancer Researchno. 7_Supplement (2023): 5665-5665

引用0浏览0引用

HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models

Hang Ke,Faming Zhang,Jingjing Wang,Lingxin Xiong,Xiaoyu An,Xiaolong Tu,Cen Chen, Yueying Wang,Binchen Mao,Sheng Guo, Cunxiang Ju, Xiangfei He,

Scientific Reportsno. 1 (2023): 1-12

引用3浏览0WOSNATURE引用

PD-1/PD-L1 signalling axis, "a double-edged sword" in DSS induced colitis mouse model

Tao Yang, Rongfei Lu,Kaixia Lian,Likun Zhang, Dawei Wang, Xinhe Feng,Xiaoyu An,Jessie (Jingjing) Wang, Carl K. Edwards

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology

Xiaoxi Xu,Rajendra Kumari,Jun Zhou,Jing Chen,Binchen Mao,Jingjing Wang,Meiling Zheng,Xiaolong Tu,Xiaoyu An,Xiaobo Chen,Likun Zhang,Xiaoli Tian,

PLoS One（2023）

引用3浏览0WOS引用

BALB/c-CD3EDG HuGEMM? mouse model for evaluation of CD3-targeted tumor immunotherapy

Demi Xiaojuan Liu, Kaixia Lian,Xuefei Yan, Jie Lin, Lei Zheng,Annie Xiaoyu An,Xiaoxi Xu, Ludovic Bourre,Jingjing Wang

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn